Skip to main content
Equibles

Arthur Tzianabos

Chairman

Stoke Therapeutics, Inc. (STOK)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Arthur Tzianabos

Arthur Tzianabos is recorded as Chairman at Stoke Therapeutics, Inc. (STOK). Stoke Therapeutics, Inc. reported in an 8-K filed October 6, 2025 that Arthur Tzianabos resigned as Interim Executive Chair of the Board, effective October 6, 2025. Stoke Therapeutics, Inc. reported in an 8-K filed March 18, 2025 that Arthur Tzianabos was appointed Interim Executive Chair of the Board, effective March 19, 2025.

“In connection with the Smith Appointment, and as of the Effective Date, Dr. Tzianabos resigned from the role of Interim Executive Chair of the Board and resumed his status as an independent director and will remain Chair of the Board.”
Stoke Therapeutics, Inc. Form 8-K, filed October 6, 2025 · Read the filing
“Also in connection with Dr. Kaye's transition, effective as of the Transition Date, the Board appointed Arthur Tzianabos, 61, currently Chair of the Board, as Interim Executive Chair of the Board.”
Stoke Therapeutics, Inc. Form 8-K, filed March 18, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Stoke Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.